Rapid Therapeutic Science Laboratories, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Rapid Therapeutic Science Laboratories, Inc. reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $48.78 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2023-08-14
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2023-06-30 was $14.90K, a 86.76% decline year-over-year.
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2023-03-31 was $33.88K, a 74.36% decline year-over-year.
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2022-12-31 was -$270.70K, a 617.69% decline year-over-year.
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2022-09-30 was $153.56K.
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $127.52K, a 23.27% increase from fiscal 2021.
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2021 was $103.44K, a 116.77% increase from fiscal 2020.
- Rapid Therapeutic Science Laboratories, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was $47.72K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-06-30 | $14.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $48.78K 10-Q · filed 2023-08-14 | -$221.93K derived: sum of 3 quarters · filed 2023-08-14 | -$68.36K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2023-03-31 | $33.88K 10-Q · filed 2023-05-12 | -$236.82K derived: sum of 2 quarters · filed 2023-05-12 | -$83.26K derived: sum of 3 quarters · filed 2023-05-12 | $29.28K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-12-31 | -$270.70K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$117.14K derived: sum of 2 quarters · filed 2023-03-30 | -$4.60K derived: sum of 3 quarters · filed 2023-08-14 | $127.52K 10-K · filed 2023-03-30 | ||
| 2022-09-30 | $153.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $266.10K derived: sum of 2 quarters · filed 2023-08-14 | $398.22K 10-Q · filed 2022-11-10 | $450.51K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-06-30 | $112.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $244.66K 10-Q · filed 2023-08-14 | $296.95K derived: sum of 3 quarters · filed 2023-08-14 | $285.57K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $132.12K 10-Q · filed 2023-05-12 | $426.51K 10-Q · filed 2022-05-11 | $184.41K derived: sum of 2 quarters · filed 2023-05-12 | $173.04K derived: sum of 3 quarters · filed 2023-05-12 | $258.01K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $52.29K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $40.92K derived: sum of 2 quarters · filed 2023-03-30 | $125.89K derived: sum of 3 quarters · filed 2023-03-30 | $103.44K 10-K · filed 2023-03-30 | $82.19K 10-K · filed 2022-03-16 | |
| 2021-09-30 | -$11.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $73.60K derived: sum of 2 quarters · filed 2022-11-10 | $51.15K 10-Q · filed 2022-11-10 | $107.17K derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $84.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $62.53K 10-Q · filed 2022-08-12 | $118.55K derived: sum of 3 quarters · filed 2022-08-12 | $104.26K derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | -$22.45K 10-Q · filed 2022-05-11 | $33.57K derived: sum of 2 quarters · filed 2022-05-11 | $19.29K derived: sum of 3 quarters · filed 2022-05-11 | $38.13K derived: sum of 4 quarters · filed 2022-05-11 | ||
| 2020-12-31 | $56.02K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | $41.73K derived: sum of 2 quarters · filed 2022-03-16 | $60.58K derived: sum of 3 quarters · filed 2022-03-16 | $47.72K 10-K · filed 2022-03-16 | ||
| 2020-09-30 | -$14.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $4.56K derived: sum of 2 quarters · filed 2021-11-10 | -$8.30K 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $18.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $5.99K 10-Q · filed 2021-08-11 | ||||
| 2020-03-31 | -$12.86K 10-Q · filed 2021-05-14 |